FDA official logo
GSRS logo
PFDA official logo

DEPATUXIZUMAB MAFODOTIN

  • UNII: F3R7A4P04N
  • Preferred Substance Name: DEPATUXIZUMAB MAFODOTIN

  • 1585973-65-4
  • ABT-414
  • DEPATUXIZUMAB MAFODOTIN [INN]
  • DEPATUXIZUMAB MAFODOTIN [JAN]
  • DEPATUXIZUMAB MAFODOTIN [USAN]
  • DEPATUXIZUMAB MAFODOTIN [WHO-DD]
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN F

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.